PHARMACYTE BIOTECH, INC. (PMCB) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-07-31..
Operating margin
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-07-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -7.01M USD | Operating Income (Loss) |
| Revenue | 0.00 USD | |
| Cost of products and services | (m) | |
| Research and development | 356.14K USD | Research and Development Expense |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-07-31 | $-7.01M | $0.00 | (m) | $356.14K | (m) | (m) |
| 2026-04-30 | $-6.85M | $0.00 | (m) | $391.30K | (m) | (m) |
| 2026-01-31 | $-5.38M | $0.00 | (m) | $456.09K | (m) | (m) |
| 2025-10-31 | $-4.23M | $0.00 | (m) | $481.17K | (m) | (m) |
| 2025-07-31 | $-3.96M | $0.00 | (m) | $437.56K | (m) | (m) |
| 2025-04-30 | $-4.38M | $0.00 | (m) | $438.42K | (m) | (m) |
| 2025-01-31 | $-6.50M | $0.00 | (m) | $405.87K | (m) | (m) |
| 2024-10-31 | $-7.41M | $0.00 | (m) | $414.40K | (m) | (m) |
| 2024-07-31 | $-7.71M | $0.00 | (m) | $398.96K | (m) | (m) |
| 2024-04-30 | $-8.52M | $0.00 | (m) | $407.43K | (m) | (m) |
| 2024-01-31 | $-6.26M | $0.00 | (m) | $399.12K | (m) | (m) |
| 2023-10-31 | $-5.94M | $0.00 | (m) | $317.78K | (m) | (m) |
| 2023-07-31 | $-6.85M | $0.00 | (m) | $413.75K | (m) | (m) |
| 2023-04-30 | $-6.46M | $0.00 | (m) | $468.54K | (m) | (m) |
| 2023-01-31 | $-7.06M | $0.00 | (m) | $636.73K | (m) | (m) |
| 2022-10-31 | $-6.36M | $0.00 | (m) | $749.37K | (m) | (m) |
| 2022-07-31 | $-5.05M | $0.00 | (m) | $706.60K | (m) | (m) |
| 2022-04-30 | $-4.39M | $0.00 | (m) | $690.94K | (m) | (m) |
| 2022-01-31 | $-3.92M | $0.00 | (m) | $757.14K | (m) | (m) |
| 2021-10-31 | $-3.82M | $0.00 | (m) | $773.19K | (m) | (m) |
| 2021-07-31 | $-3.76M | $0.00 | (m) | $789.29K | (m) | (m) |
| 2021-04-30 | $-3.62M | $0.00 | (m) | $916.25K | (m) | (m) |
| 2021-01-31 | $-3.34M | $0.00 | (m) | $693.63K | (m) | (m) |
| 2020-10-31 | $-3.46M | $0.00 | (m) | $632.84K | (m) | (m) |
| 2020-07-31 | $-3.57M | $0.00 | (m) | $499.46K | (m) | (m) |
| 2020-04-30 | $-3.83M | $0.00 | (m) | $301.22K | (m) | (m) |
| 2020-01-31 | $-4.25M | $0.00 | (m) | $221.58K | (m) | (m) |
| 2019-10-31 | $-4.05M | $0.00 | (m) | $167.43K | (m) | (m) |
| 2019-07-31 | $-4.02M | $0.00 | (m) | $264.59K | (m) | (m) |
| 2019-04-30 | $-4.10M | $0.00 | (m) | $460.05K | (m) | (m) |
| 2019-01-31 | $-4.38M | $0.00 | (m) | $694.16K | (m) | (m) |
| 2018-10-31 | $-5.73M | $0.00 | (m) | $1.44M | (m) | (m) |
| 2018-07-31 | $-6.51M | $0.00 | (m) | $1.84M | (m) | (m) |
| 2018-04-30 | $-6.98M | $0.00 | (m) | $2.00M | (m) | (m) |
| 2018-01-31 | $-6.69M | $0.00 | (m) | $1.92M | (m) | (m) |
| 2017-10-31 | $-5.94M | $0.00 | (m) | $1.70M | (m) | (m) |
| 2017-07-31 | $-5.10M | $0.00 | (m) | $1.43M | (m) | (m) |
| 2017-04-30 | $-4.44M | $0.00 | (m) | $1.18M | (m) | (m) |
| 2017-01-31 | $-4.42M | $0.00 | (m) | $1.25M | (m) | (m) |
| 2016-10-31 | $-4.93M | $0.00 | (m) | $1.24M | (m) | (m) |
| 2016-07-31 | $-5.59M | $0.00 | (m) | $1.43M | (m) | (m) |
| 2016-04-30 | $-6.07M | $0.00 | (m) | $1.41M | (m) | (m) |
| 2016-01-31 | $-8.92M | $0.00 | (m) | $4.02M | (m) | (m) |
| 2015-10-31 | $-8.00M | $0.00 | (m) | $3.72M | (m) | (m) |
| 2015-07-31 | $-13.12M | $0.00 | (m) | $3.63M | (m) | (m) |
| 2015-04-30 | $-13.70M | $0.00 | (m) | $3.48M | (m) | (m) |
| 2015-01-31 | $-25.73M | $0.00 | (m) | (m) | (m) | (m) |
| 2014-10-31 | $-24.96M | $0.00 | (m) | (m) | (m) | (m) |
| 2014-07-31 | $-19.16M | $0.00 | (m) | (m) | (m) | (m) |
| 2014-04-30 | $-18.98M | $0.00 | (m) | (m) | (m) | (m) |
| 2014-01-31 | $-2.99M | $0.00 | (m) | (m) | (m) | (m) |
| 2013-10-31 | $-2.65M | $-753.00 | (m) | (m) | (m) | 351399.73% |
| 2013-07-31 | $-2.55M | $5.53K | (m) | (m) | (m) | -46011.31% |
| 2013-04-30 | $-1.68M | $12.16K | (m) | (m) | (m) | -13851.65% |
| 2013-01-31 | (m) | $18.84K | (m) | (m) | (m) | (m) |
| 2012-10-31 | (m) | $39.87K | (m) | (m) | (m) | (m) |
| 2012-07-31 | (m) | $53.42K | (m) | (m) | (m) | (m) |
| 2012-04-30 | (m) | $66.56K | (m) | (m) | (m) | (m) |
| 2012-01-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-10-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-01-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-10-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |